Objective To investigate the expression of PAX-5 in
anaplastic large cell lymphoma, discuss the value and pitfalls of PAX-5 in the
diagnosis and
differential diagnosis of
lymphomas.
Methods A total of 269 T
lymphomas were studied retrospectively.PAX-5 positive
anaplastic large cell lymphoma was confirmed by immo-munohistochemistry and
gene rearrangement analysis.
Literature review was performed and the clinicopathological features were discussed.Results Two cases of
anaplastic large cell lymphoma were found with aberrant expression of PAX-5. Conclusions As a relatively specific B
cell marker, PAX-5 can also express in
anaplastic large cell lymphoma. In the
diagnosis of
lymphomas, especially the
differential diagnosis between classical Hodgkin lympho-ma and
Anaplastic large-cell lymphoma,
diagnosis errors should be avoided by interpreting PAX-5 immunohisto-
chemistry in the context of clinical features, morphology, a panel of B- and T-lineage-associated
antibodies, and
gene rearrangement analysis.